BRCA1 and angiosarcoma: Radiation-induced angiosarcomas with BRCA1 mutations are defective in the homologous recombination repair pathway and may be susceptible to platinum-based chemotherapy and poly ADP-ribose polymerase (PARP) inhibitors, and this case was also considered for clinical trials of PARP as a treatment option.